Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of Storage-Induced mRNA Modifications in (<i>4S</i>)-KEL12 LNP: Adduct Formation Kinetics, mRNA Decay, and Translational Competence.

Molecular pharmaceutics·2026
Same author

Mutation of the highly conserved amino acids in the N-terminal region of the EV-A71 VP1 protein impairs viral RNA release during virus entry.

Microbiology spectrum·2026
Same author

SLFN14 functions as a P-TEFb inhibitor to modulate the transcription of HIV-1 and cellular genes.

Science advances·2025
Same author

Design, Synthesis, and Biological Evaluation of Novel Core Scaffold-Modified HIV-1 Protease Inhibitors for Overcoming Drug Resistance.

Journal of medicinal chemistry·2025
Same author

SLFN11 Restricts LINE-1 Mobility.

Cells·2025
Same author

Novel virulence determinants in VP1 regulate the assembly of enterovirus-A71.

Journal of virology·2024

Related Experiment Video

Updated: Sep 12, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.3K

Lipid Nanoparticle-Encapsulated mRNAs Encoding Tumor-Specific Toxin Proteins Selectively Target Cancer Cells and

Rui Zhou1, Lu Han2, Jing Wang1

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Science, Beijing, China.

Cancer Research
|August 4, 2025
PubMed
Summary

Messenger RNA (mRNA) therapeutics encoding tumor-specific toxins, like neutrophil elastase (ELANE), show promise for cancer treatment. Lipid nanoparticle-encapsulated mRNA effectively killed cancer cells and inhibited tumor growth without toxicity in preclinical models.

More Related Videos

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

12.0K

Related Experiment Videos

Last Updated: Sep 12, 2025

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells
10:02

Using Lipid Nanoparticles for the Delivery of Chemically Modified mRNA into Mammalian Cells

Published on: June 10, 2022

2.3K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

2.8K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

12.0K

Area of Science:

  • Oncology
  • Biotechnology
  • Molecular Therapy

Background:

  • Messenger RNA (mRNA)-based therapeutics offer a promising avenue for treating various diseases.
  • Tumor-specific toxins are ideal candidates for mRNA-based cancer therapeutics due to their targeted action.

Purpose of the Study:

  • To investigate the anti-tumor potential of lipid nanoparticle (LNP)-encapsulated mRNA encoding the tumor-specific toxin protein neutrophil elastase (ELANE or PPE).

Main Methods:

  • In vitro studies using cancer and non-cancer cell lines treated with ELANE or PPE mRNA-LNPs.
  • In vivo studies in mice administering ELANE and PPE mRNA-LNPs to assess tumor growth inhibition and toxicity.
  • Analysis of CD8+ T cell infiltration in tumors post-treatment.

Main Results:

  • ELANE or PPE mRNA-LNP treatment selectively killed various cancer cell types in vitro, sparing non-cancer cells.
  • Significant inhibition of tumor growth was observed in vivo following mRNA-LNP administration.
  • Treatment induced CD8+ T cell infiltration into tumors and showed no acute toxicity in mice.
  • Other elastases from different species also demonstrated efficacy against cancer cells.

Conclusions:

  • Tumor-specific toxin protein mRNA-LNPs represent a viable therapeutic strategy for cancer.
  • Further development of this approach is supported by the preclinical data, highlighting its potential for targeted cancer therapy.